Terns Raises $87m More For NASH R&D, Including Lilly Equity Purchase

 
• By Joseph Haas
  
Financial Investment
Deerfield and Eli Lilly are notable names among Terns' series C investors
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business